DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories
02 1Breckenridge Pharmaceutical
03 2NanoAlvand
04 2Ajanta Pharma Limited
05 2Annora Pharma
06 2Auro Pharma Inc
07 2Aurobindo Pharma Limited
08 2Bluepharma
09 3DelNova Healthcare
10 2Devatis AG
11 2Dexcel Pharma
12 1Hikma Pharmaceuticals
13 2Intas Pharmaceuticals
14 1JAMP PHARMA
15 2Laboratorio Eczane Pharma
16 2MSN Laboratories
17 1Micro Labs Limited
18 15Pfizer Consumer Healthcare
19 15Pfizer Inc
20 1Pharmascience Inc.
21 3Pluviaendo
22 1Prinston
23 2Pulse Pharmaceuticals
24 2Sandoz B2B
25 3Taro Pharmaceutical Industries
26 1Unichem Laboratories Limited
27 2Yaopharma
28 3Zydus Pharmaceuticals
Reset all filters
01 3Extended Release Tablet
02 1Extended-Release Tablet
03 1FCT
04 11Film Coated Tablet
05 1Film Coated XR Tablet
06 1Oral Solid Dosage Form
07 2Oral Solution
08 2SOLUTION;ORAL
09 2SR Tablet
10 11TABLET
11 2TABLET (EXTENDED-RELEASE)
12 8TABLET, EXTENDED RELEASE;ORAL
13 11TABLET;ORAL
14 7Tablet
15 11tablet
16 4Blank
Reset all filters
01 6Allowed
02 4Authorized
03 8DISCN
04 1Generic
05 1Lead Market Dossiers- Under Development
06 1Originator
07 10Prescription
08 6RX
09 41Blank
Reset all filters
01 2AURO-TOFACITINIB
02 1JAMP TOFACITINIB
03 1PMS-TOFACITINIB
04 2Rhofanib
05 2TARO-TOFACITINIB
06 1TARO-TOFACITINIB XR
07 7TOFACITINIB
08 10TOFACITINIB CITRATE
09 2Tofacitinib
10 2Tofacitinib Devatis
11 2Tofacitinib Sandoz
12 2Tofax
13 1Tofaxen 11 XR
14 1Tofaxen 5
15 5XELJANZ
16 5XELJANZ XR
17 22Xeljanz
18 1Xeljanz 5 mg
19 9Blank
Reset all filters
01 2Argentina
02 15Australia
03 10Canada
04 9India
05 2Iran
06 2Portugal
07 1South Africa
08 4Spain
09 6Switzerland
10 3Turkey
11 24USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 22MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209633
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Rhofanib
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Rhofanib
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2021-06-01
Application Number : 212943
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 215356
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2023-09-25
Application Number : 216878
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2023-03-13
Application Number : 209738
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 217299
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2012-11-06
Application Number : 203214
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2018-05-30
Application Number : 203214
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11MG BASE
Packaging :
Approval Date : 2016-02-23
Application Number : 208246
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 22MG BASE
Packaging :
Approval Date : 2019-12-12
Application Number : 208246
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XELJANZ
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2020-09-25
Application Number : 213082
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TOFACITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209923
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Tofacitinib
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 215552
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Tofacitinib
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 215552
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2023-03-13
Application Number : 209829
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11MG BASE
Packaging :
Approval Date : 2021-08-19
Application Number : 214264
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TOFACITINIB CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 22MG BASE
Packaging :
Approval Date : 2021-08-19
Application Number : 214264
Regulatory Info : DISCN
Registration Country : USA